Evaluation anti-inflammatory and anti-oxidant activity of simvastatin in asthma

Journal of the Bahrain Medical Society

Volumn 20, Issue 2, 2008, Pages 55-59

  Al Obaidi, Amina Hamed Ahmad ^a   Al Samarai, Abdul Ghani Mohamed ^a  

^a TIKRIT UNIVERSITY   (Iraq)

Author keywords

Asthma; Simvastatin

Indexed keywords

C REACTIVE PROTEIN; EOSINOPHIL CATIONIC PROTEIN; IRON; MALONALDEHYDE; SIMVASTATIN;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IRON BLOOD LEVEL; OXIDATIVE STRESS; THERAPY EFFECT;

EID: 55049142175     PISSN: 10156321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bonetti PO, Lerman LO, Napoli C, Lerman A,. Statin effect beyond lipid lowering - are they clinically relevant? Eur Heart J 2003;24:225-248.
2. Wood LG, Gibson PG, Garg ML. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 2003;21:177-186.
3. McKay A, Leung B, McInnes I, Thomas N, Liew F. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 2004;172:2903-2908.
4. Kwak B, Mulhaupt F, Myit S et al. Statins as newly recognized type of immunomodulator. Nat Med 2000;6:1399-402.
5. Zubelewicz B, Szkodzinski J, Romanowski W, Blazelonis A, Danikiewicz A, Muc Wierizgon M, Szkilnik R. Simavastatine decreases concentration of IL-2 in hypercholesterolemic patients after treatment for 2 weeks. J Biol Regul Homeost Agents 2004;18:295-301.
6. Pasceri V, Chang J, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerotic drugs. Circulation. 2001;103:2531-2534
7. Ferro D, Parrotto S, Basili S, Allesandri C, Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol 2000;36:427-431.
8. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. NIH Publication 02-3659. Bethesda, MD: NHLBI, 2002.
9. Kampa M, Nistikaki A, Tsaousis V, Maliaraki N, Notas G, Gastonas E. A new automated method for the determination of TAC of human plasma based on crocin bleaching assay. BMC Clin Pathol 2002;2:3-21.
10. Janero D. Malondialdehyde and thiobarbituric acid reactivity as diagnostic indicies of lipid peroxidationand peroxidative tissue injury. Free Rad Bio Med 1998;9:515-540.
11. Ikeda U, Ito T, Shimada K. Statins and C reactive protein. Lancet 1999;353: 1274-5.
12. Inoue I, Goto S, Mizotani K et al. Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of mRNA levels for intrleukin-1B, Interlukin-6, cyclooxigenase-2, and p22phox by regulation of peroxisome proliferators activated receptor alfa in primary endothelial cells. Life Sci 2000; 67:863-76.
13. Robinson DS. Immunological mechanisms in asthma and allergic diseases. Chemical Immunology 2003;78:1-205.
14. Seroogy CM, Gern J. The role of T regulatory cells in asthma. J Allergy Clin Immunol 2005;116:996-9.
15. Luo FM. Simvastatin induces eosinophil apoptosis in vitro. Chest 2004;126:S721.
16. Busse WW, Coffman RL, Gelfand EW, Kay AB, Rosenwasser LJ. Mechanisms of persistent airway inflammation in asthma: a role for T cells and T-cell products. Am J Respir Crit Care Med 1995; 152: 388-393.
17. Beltwski J, Wojcick GG, Mydlarczyk M, Jamro ZA. Cervastatin modulates plasma paraoxinase/Arylesterase activity and oxidant - antioxidant balance in the rat. Polish J Pharmacol 2002;54:143-150.
18. Sager PT, Melani L, Lipka L, et al. Effect of coadministration of ezetimibe and simvastatin on high sensitivity C reactive protein. Am J Cardiol 2003;92:1414-1418.
19. Ridker PM, Rifai N, Clearfield M, et al. Measurment of CRP for the targeting of statin therapy in the primary prevention of acute coronary events. N Eng J Med 2001;344:1959-1965.
20. Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005;115:897-909.